144 related articles for article (PubMed ID: 7988269)
1. The adverse effect of perioperative blood transfusion in lung cancer.
Piantadosi S; Moores DW; McKneally MF
Chest; 1994 Dec; 106(6 Suppl):382S-384S. PubMed ID: 7988269
[TBL] [Abstract][Full Text] [Related]
2. Effect of perioperative blood transfusion on outcome in patients with surgically resected lung cancer.
Moores DW; Piantadosi S; McKneally MF
Ann Thorac Surg; 1989 Mar; 47(3):346-51. PubMed ID: 2539064
[TBL] [Abstract][Full Text] [Related]
3. Perioperative blood transfusion and prognosis of resected stage Ia lung cancer.
Pastorino U; Valente M; Cataldo I; Lequaglie C; Ravasi G
Eur J Cancer Clin Oncol; 1986 Nov; 22(11):1375-8. PubMed ID: 3030760
[TBL] [Abstract][Full Text] [Related]
4. Blood transfusion and lung cancer recurrence.
Keller SM; Groshen S; Kaiser LR
Ann Thorac Surg; 1989 Nov; 48(5):746-7. PubMed ID: 2554830
[No Abstract] [Full Text] [Related]
5. The adverse effect of blood transfusion in lung cancer.
Piantadosi S
Chest; 1992 Jul; 102(1):6-8. PubMed ID: 1320566
[No Abstract] [Full Text] [Related]
6. Perioperative blood transfusion adversely affects prognosis of patients with stage I non-small-cell lung cancer.
Little AG; Wu HS; Ferguson MK; Ho CH; Bowers VD; Segalin A; Staszek VM
Am J Surg; 1990 Dec; 160(6):630-2; discussion 633. PubMed ID: 2174651
[TBL] [Abstract][Full Text] [Related]
7. Correlation between perioperative blood transfusion and prognosis of patients subjected to surgery for stage I lung cancer.
Nosotti M; Rebulla P; Riccardi D; Baisi A; Bellaviti N; Rosso L; Santambrogio L
Chest; 2003 Jul; 124(1):102-7. PubMed ID: 12853510
[TBL] [Abstract][Full Text] [Related]
8. Significance of perioperative blood transfusions in patients undergoing resection of stage I and II non-small-cell lung cancers.
Pena CM; Rice TW; Ahmad M; Medendorp SV
Chest; 1992 Jul; 102(1):84-8. PubMed ID: 1320567
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors for post-recurrence survival in patients with completely resected Stage I non-small-cell lung cancer.
Song IH; Yeom SW; Heo S; Choi WS; Yang HC; Jheon S; Kim K; Cho S
Eur J Cardiothorac Surg; 2014 Feb; 45(2):262-7. PubMed ID: 23811122
[TBL] [Abstract][Full Text] [Related]
10. Risk factors associated with recurrence of surgically resected node-positive non-small cell lung cancer.
Ohtaki Y; Shimizu K; Kaira K; Nagashima T; Obayashi K; Nakazawa S; Kakegawa S; Igai H; Kamiyoshihara M; Nishiyama M; Takeyoshi I
Surg Today; 2016 Oct; 46(10):1196-208. PubMed ID: 26782692
[TBL] [Abstract][Full Text] [Related]
11. Predictors of death, local recurrence, and distant metastasis in completely resected pathological stage-I non-small-cell lung cancer.
Hung JJ; Jeng WJ; Hsu WH; Chou TY; Huang BS; Wu YC
J Thorac Oncol; 2012 Jul; 7(7):1115-23. PubMed ID: 22592210
[TBL] [Abstract][Full Text] [Related]
12. Perioperative blood transfusion adversely affects prognosis after resection of lung cancer: a systematic review and a meta-analysis.
Luan H; Ye F; Wu L; Zhou Y; Jiang J
BMC Surg; 2014 May; 14():34. PubMed ID: 24884867
[TBL] [Abstract][Full Text] [Related]
13. Leukocyte-depleted blood transfusion is associated with decreased survival in resected early-stage lung cancer.
Ng T; Ryder BA; Chern H; Sellke FW; Machan JT; Harrington DT; Cioffi WG
J Thorac Cardiovasc Surg; 2012 Apr; 143(4):815-9. PubMed ID: 22325327
[TBL] [Abstract][Full Text] [Related]
14. Cytoplasmic and nuclear parathyroid hormone-related proteins are opposing prognostic factors in patients with non-small-cell lung cancer who have undergone curative resection.
Wu CE; Wang CW; Huang WK; Yang CT; Wu YC; Hou MM; Hsieh CH; Hsieh JJ; Cheng HY; Hsu T; Chang JW
Jpn J Clin Oncol; 2015 Mar; 45(3):267-73. PubMed ID: 25480982
[TBL] [Abstract][Full Text] [Related]
15. Perioperative blood transfusion is associated with worse clinical outcomes in resected lung cancer.
Wang T; Luo L; Huang H; Yu J; Pan C; Cai X; Hu B; Yin X
Ann Thorac Surg; 2014 May; 97(5):1827-37. PubMed ID: 24674755
[TBL] [Abstract][Full Text] [Related]
16. Identification of subsets of patients with favorable prognosis after recurrence in completely resected non-small cell lung cancer.
Sonobe M; Yamada T; Sato M; Menju T; Aoyama A; Sato T; Chen F; Omasa M; Bando T; Date H
Ann Surg Oncol; 2014 Aug; 21(8):2546-54. PubMed ID: 24633668
[TBL] [Abstract][Full Text] [Related]
17. Operable non-small cell lung cancer diagnosed by transpleural techniques : do they affect relapse and prognosis?
Sawabata N; Maeda H; Ohta M; Hayakawa M
Chest; 2001 Nov; 120(5):1595-8. PubMed ID: 11713140
[TBL] [Abstract][Full Text] [Related]
18. [Influence of blood transfusion on postoperative prognosis of stage I (No) lung cancer].
Wu HS
Zhonghua Zhong Liu Za Zhi; 1989 Jul; 11(4):297-9. PubMed ID: 2560426
[TBL] [Abstract][Full Text] [Related]
19. Influence of blood transfusions and preoperative anemia on long-term survival in patients operated for non-small cell lung cancer.
Panagopoulos ND; Karakantza M; Koletsis E; Apostolakis E; Sakellaropoulos GC; Filos KS; Eleni T; Dougenis D
Lung Cancer; 2008 Nov; 62(2):273-80. PubMed ID: 18430486
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with recurrence in patients with curatively resected stage I-II lung cancer.
Koo HK; Jin SM; Lee CH; Lim HJ; Yim JJ; Kim YT; Yang SC; Yoo CG; Han SK; Kim JH; Shim YS; Kim YW
Lung Cancer; 2011 Aug; 73(2):222-9. PubMed ID: 21168237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
